India to Venezuela: Bevacizumab Export Trade Route

The India to Venezuela Bevacizumab corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $1.4M USD. The route is dominated by MEDWISE OVERSEAS PRIVATE LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $206.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 15.2%, placing it at rank #14 among India's top bevacizumab export destinations globally.

On the import side, key buyers of Indian bevacizumab in Venezuela include TO MEDICAMENTOS CONSUMOSASIA CA, WELL AND TECH MEDICAL LTD., TO THE ORDER OF, ATTENTION TO THE P and 3 others. TO MEDICAMENTOS CONSUMOSASIA CA is the single largest importer with 1 shipments valued at $699.0K USD.

India's bevacizumab exports to Venezuela are driven primarily by a handful of large-scale manufacturers. MEDWISE OVERSEAS PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Venezuela benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDWISE OVERSEAS PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, RTM HEALTHCARE PRIVATE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $206.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as bevacizumab injection 400 mg/16ml (5000 vial) and medicine for human consumption : bevacizumab 400 mg / 16 ml, suggesting that buyers in Venezuela tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO MEDICAMENTOS CONSUMOSASIA CA is the largest importer with 1 shipments worth $699.0K USD — representing 48% of all bevacizumab imports from India on this route. A total of 6 buyers are active on this corridor.